Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor ThrombosisShaohua Li, Qing Li, Ming Shi et al.|PLoS ONE|2015Cited by 40
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual diseaseWenyi Lu, Mingfeng Zhao, Hairong Lyu et al.|Cancer Immunology Immunotherapy|2021Cited by 22
Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinomaMinKe He, Ming Shi, Qing Li et al.|Cancer Medicine|2019Cited by 8